Cargando…

Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy

The gut microbiota not only constitutes intestinal microenvironment homeostasis and human health but also exerts indispensable roles in the occurrence and progression of multiple liver diseases, including alcohol-related liver disease, nonalcoholic fatty liver disease, autoimmune liver disease and l...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Li-Ran, Li, Shan-Shan, Zheng, Wan-Qun, Ni, Wei-Jian, Cai, Ming, Liu, Hai-Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933143/
https://www.ncbi.nlm.nih.gov/pubmed/36817459
http://dx.doi.org/10.3389/fimmu.2023.1086078
_version_ 1784889609310699520
author Zhu, Li-Ran
Li, Shan-Shan
Zheng, Wan-Qun
Ni, Wei-Jian
Cai, Ming
Liu, Hai-Peng
author_facet Zhu, Li-Ran
Li, Shan-Shan
Zheng, Wan-Qun
Ni, Wei-Jian
Cai, Ming
Liu, Hai-Peng
author_sort Zhu, Li-Ran
collection PubMed
description The gut microbiota not only constitutes intestinal microenvironment homeostasis and human health but also exerts indispensable roles in the occurrence and progression of multiple liver diseases, including alcohol-related liver disease, nonalcoholic fatty liver disease, autoimmune liver disease and liver cancer. Given the therapeutic status of these diseases, their prevention and early therapy are crucial, and the detailed mechanism of gut microbiota in liver disease urgently needs to be explored. Meanwhile, multiple studies have shown that various traditional Chinese medicines, such as Si Miao Formula, Jiangzhi Granules, Liushen Capsules, Chaihu-Shugan Power, Cassiae Semen and Gynostemma, as well as some natural products, including Costunolide, Coprinus comatus polysaccharide, Antarctic krill oil, Oridonin and Berberine, can repair liver injury, improve fatty liver, regulate liver immunity, and even inhibit liver cancer through multiple targets, links, and pathways. Intriguingly, the aforementioned effects demonstrated by these traditional Chinese medicines and natural products have been shown to be closely related to the gut microbiota, directly driving the strategy of traditional Chinese medicines and natural products to regulate the gut microbiota as one of the breakthroughs in the treatment of liver diseases. Based on this, this review comprehensively summarizes and discusses the characteristics, functions and potential mechanisms of these medicines targeting gut microbiota during liver disease treatment. Research on the potential effects on gut microbiota and the regulatory mechanisms of traditional Chinese medicine and natural products provides novel insights and significant references for developing liver disease treatment strategies. In parallel, such explorations will enhance the comprehension of traditional Chinese medicine and natural products modulating gut microbiota during disease treatment, thus facilitating their clinical investigation and application.
format Online
Article
Text
id pubmed-9933143
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99331432023-02-17 Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy Zhu, Li-Ran Li, Shan-Shan Zheng, Wan-Qun Ni, Wei-Jian Cai, Ming Liu, Hai-Peng Front Immunol Immunology The gut microbiota not only constitutes intestinal microenvironment homeostasis and human health but also exerts indispensable roles in the occurrence and progression of multiple liver diseases, including alcohol-related liver disease, nonalcoholic fatty liver disease, autoimmune liver disease and liver cancer. Given the therapeutic status of these diseases, their prevention and early therapy are crucial, and the detailed mechanism of gut microbiota in liver disease urgently needs to be explored. Meanwhile, multiple studies have shown that various traditional Chinese medicines, such as Si Miao Formula, Jiangzhi Granules, Liushen Capsules, Chaihu-Shugan Power, Cassiae Semen and Gynostemma, as well as some natural products, including Costunolide, Coprinus comatus polysaccharide, Antarctic krill oil, Oridonin and Berberine, can repair liver injury, improve fatty liver, regulate liver immunity, and even inhibit liver cancer through multiple targets, links, and pathways. Intriguingly, the aforementioned effects demonstrated by these traditional Chinese medicines and natural products have been shown to be closely related to the gut microbiota, directly driving the strategy of traditional Chinese medicines and natural products to regulate the gut microbiota as one of the breakthroughs in the treatment of liver diseases. Based on this, this review comprehensively summarizes and discusses the characteristics, functions and potential mechanisms of these medicines targeting gut microbiota during liver disease treatment. Research on the potential effects on gut microbiota and the regulatory mechanisms of traditional Chinese medicine and natural products provides novel insights and significant references for developing liver disease treatment strategies. In parallel, such explorations will enhance the comprehension of traditional Chinese medicine and natural products modulating gut microbiota during disease treatment, thus facilitating their clinical investigation and application. Frontiers Media S.A. 2023-02-02 /pmc/articles/PMC9933143/ /pubmed/36817459 http://dx.doi.org/10.3389/fimmu.2023.1086078 Text en Copyright © 2023 Zhu, Li, Zheng, Ni, Cai and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Zhu, Li-Ran
Li, Shan-Shan
Zheng, Wan-Qun
Ni, Wei-Jian
Cai, Ming
Liu, Hai-Peng
Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy
title Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy
title_full Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy
title_fullStr Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy
title_full_unstemmed Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy
title_short Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy
title_sort targeted modulation of gut microbiota by traditional chinese medicine and natural products for liver disease therapy
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933143/
https://www.ncbi.nlm.nih.gov/pubmed/36817459
http://dx.doi.org/10.3389/fimmu.2023.1086078
work_keys_str_mv AT zhuliran targetedmodulationofgutmicrobiotabytraditionalchinesemedicineandnaturalproductsforliverdiseasetherapy
AT lishanshan targetedmodulationofgutmicrobiotabytraditionalchinesemedicineandnaturalproductsforliverdiseasetherapy
AT zhengwanqun targetedmodulationofgutmicrobiotabytraditionalchinesemedicineandnaturalproductsforliverdiseasetherapy
AT niweijian targetedmodulationofgutmicrobiotabytraditionalchinesemedicineandnaturalproductsforliverdiseasetherapy
AT caiming targetedmodulationofgutmicrobiotabytraditionalchinesemedicineandnaturalproductsforliverdiseasetherapy
AT liuhaipeng targetedmodulationofgutmicrobiotabytraditionalchinesemedicineandnaturalproductsforliverdiseasetherapy